Abbvie CDR (Cad Hedged) (ABBV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,987,000 | 2,063,000 | 2,050,000 | 2,039,000 | 2,102,000 |
| Income taxes - deferred | -385,000 | 193,000 | -272,000 | -28,000 | -767,000 |
| Accounts receivable | 162,000 | -156,000 | -17,000 | -1,479,000 | 387,000 |
| Accounts payable and accrued liabilities | -598,000 | 1,730,000 | 515,000 | -696,000 | 1,247,000 |
| Other Working Capital | -473,000 | 1,253,000 | -562,000 | -2,580,000 | -397,000 |
| Other Operating Activity | 4,525,000 | 1,941,000 | 3,439,000 | 4,379,000 | 4,476,000 |
| Operating Cash Flow | $5,218,000 | $7,024,000 | $5,153,000 | $1,635,000 | $7,048,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -329,000 | -381,000 | -269,000 | -235,000 | -291,000 |
| Net Acquisitions | -1,161,000 | -2,802,000 | -940,000 | -538,000 | -1,792,000 |
| Purchase Of Investment | -6,000 | -7,000 | -12,000 | -10,000 | -27,000 |
| Sale Of Investment | 34,000 | 3,000 | 7,000 | 32,000 | 39,000 |
| Other Investing Activity | -1,000 | -77,000 | 33,000 | 16,000 | 197,000 |
| Investing Cash Flow | $-1,463,000 | $-3,264,000 | $-1,181,000 | $-735,000 | $-1,874,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,291,000 | -1,766,000 | 3,963,000 | 1,593,000 | 0 |
| Debt Issued | 0 | 0 | 0 | 3,994,000 | 2,000,000 |
| Debt Repayment | -8,000 | -9,000 | -3,754,000 | -3,026,000 | -5,762,000 |
| Common Stock Repurchased | -3,000 | -4,000 | -12,000 | -961,000 | -358,000 |
| Dividend Paid | -2,911,000 | -2,911,000 | -2,910,000 | -2,925,000 | -2,752,000 |
| Other Financing Activity | 47,000 | 100,000 | 3,000 | 67,000 | 11,000 |
| Financing Cash Flow | $-4,166,000 | $-4,590,000 | $-2,710,000 | $-1,258,000 | $-6,861,000 |
| Exchange Rate Effect | 11,000 | -8,000 | 30,000 | 9,000 | -46,000 |
| Beginning Cash Position | 5,629,000 | 6,467,000 | 5,175,000 | 5,524,000 | 7,257,000 |
| End Cash Position | 5,229,000 | 5,629,000 | 6,467,000 | 5,175,000 | 5,524,000 |
| Net Cash Flow | $-411,000 | $-830,000 | $1,262,000 | $-358,000 | $-1,687,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,218,000 | 7,024,000 | 5,153,000 | 1,635,000 | 7,048,000 |
| Capital Expenditure | -329,000 | -381,000 | -269,000 | -235,000 | -291,000 |
| Free Cash Flow | 4,889,000 | 6,643,000 | 4,884,000 | 1,400,000 | 6,757,000 |